Rebecca Araujo

Rebecca Araujo is a medical writer and editor. Her work has appeared in ASH Clinical News, Blood Cancers Today, DocWire News, GU Oncology Now, and more. Rebecca received her bachelor’s degree in English from Rutgers University.

Articles by Rebecca Araujo

Rebecca AraujoPublic Health | March 27, 2025
Nurses working in hospitals with LGBTQ+ inclusive policies were more likely to recommend their hospital to others.
Read More
Rebecca AraujoMental Health | March 25, 2025
Certain interventions to prevent depression in adolescents may not be as effective in Black youth.
Rebecca AraujoLung Cancer | March 24, 2025
More early-stage lung cancers were diagnosed in individuals with a history of smoking who were adherent to annual screening.
Rebecca AraujoChronic Spontaneous Urticaria | December 16, 2024
Around 70% of patients presenting to the emergency department for urticaria received diphenhydramine.
Rebecca AraujoDiabetes | February 6, 2025
Only 11% of patients with type 1 diabetes and 1% of patients with type 2 diabetes received a CGM prescription.
Rebecca AraujoAllergy | December 12, 2024
After participation, the number of households filling epinephrine autoinjector prescriptions rose from 51% to 89%.
Rebecca AraujoAllergy | December 6, 2024
Patients with extreme anxiety about using their injectable delayed treatment by a mean of 4.3 hours from attack onset.
Rebecca AraujoASH 2024 | February 13, 2025
Area Deprivation Index was associated with overall survival in both Black and Hispanic patients.
Rebecca AraujoASH 2024 | December 4, 2024
Stigma about chronic pain and opioid use disorders may contribute to the use of negative language for patients with SCD.
Rebecca AraujoASH 2024 | February 20, 2025
Black, Hispanic, and Asian patients were underrepresented in trials compared with national lymphoma data.
Rebecca AraujoASH 2024 | December 2, 2024
Families reported the direct cash support program offered them the “ability to spend more time at their child’s ...
Rebecca AraujoAllergy | November 29, 2024
Black, Hispanic, and Asian patients were less likely to be started on subcutaneous allergen immunotherapy.
Rebecca AraujoChronic Spontaneous Urticaria | November 26, 2024
The Urticaria Activity Score is commonly utilized in chronic spontaneous urticaria clinical trials.
Rebecca AraujoASH 2024 | November 25, 2024
Outcomes for patients with intermediate-risk disease biology may be most influenced by social determinants of health.
Rebecca AraujoASTRO 2024 | December 6, 2024
Roughly half of cancer survivors surveyed reported having access to paid medical leave.
Rebecca AraujoASH 2024 | November 27, 2024
The study looked at disparities in outcomes of infusion with ide-cel or cilta-cel in patients with relapsed or refractory MM.
Rebecca AraujoASTRO 2024 | December 6, 2024
Twenty percent of Black participants felt there was “nothing for them to gain by participating in research."
Rebecca AraujoASH 2024 | November 22, 2024
Up to one-third of patients who reported food, housing, or utility insecurity also had private insurance.
Rebecca AraujoASH 2024 | November 19, 2024
A study looked at cytomolecular risk profiles in Black and Hispanic patients according to clinical trial enrollment.
Rebecca AraujoASTRO 2024 | December 6, 2024
These findings highlight the importance of racial diversity in genomic profiling and clinical trials.